Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomasz Janus is active.

Publication


Featured researches published by Tomasz Janus.


Human & Experimental Toxicology | 2011

Death caused by addictive inhalation of nitrous oxide.

Barbara Potocka-Banas; Sławomir Majdanik; Grażyna Dutkiewicz; Krzysztof Borowiak; Tomasz Janus

Intoxications with nitrous oxide have been, and still are, a rarity in forensic medicine. Apart from accidental overdose during hospital procedures, intoxication with this gas is the result of voluntary inhalation. We report the fatal case of a 32-year-old male who died during inhalation of nitrous oxide from whipped dairy cream cans and hint on the role of the internet in creating new behaviors among drug addicts. We rely on the autopsy report from the Department of Forensic Medicine, Pomeranian Medical University in Szczecin, on laboratory tests, and court files. Neither the autopsy nor the toxicologic and histopathologic tests disclosed the exact cause of death. However, circumstances in which the body was discovered were indicative that death resulted from cardiorespiratory failure. The present case is interesting with regard to its rarity, diagnostic difficulties and potential harm from nitrous oxide used by the food industry.


Journal of Forensic Sciences | 2017

Fatal Intoxication with a-PVP, a Synthetic Cathinone Derivative

Barbara Potocka-Banaś; Tomasz Janus; Sławomir Majdanik; Tomasz Banaś; Teresa Dembińska; Krzysztof Borowiak

This study presents the fatal case of a young man who was admitted to the ICAU due to sudden cardiac arrest. An interview revealed that the patient had taken some unspecified crystals. From the moment of admission, his condition deteriorated dramatically as a result of increasing circulatory insufficiency. After a few hours, sudden cardiac arrest occurred again and the patient was pronounced dead. In the course of a medicolegal autopsy, samples of biological material were preserved for toxicology tests and histopathological examination. The analysis of samples using the LC‐MS/MS technique revealed the presence of α‐PVP in the following concentrations: blood—174 ng/mL, urine—401 ng/mL, brain—292 ng/g, liver—190 ng/g, kidney—122 ng/g, gastric contents—606 ng/g. The study also presents findings from the parallel histopathological examination. Based on these findings, cardiac arrest secondary to intoxication with alpha‐PVP was determined as the direct cause of the patients death.


Human & Experimental Toxicology | 2013

Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds: Genetic aspects of addiction with the selected drugs, amphetamine, tetrahydrocannabinol and opiates

J Biskupska; Krzysztof Borowiak; K Karlin-Grażewicz; Tomasz Janus; P Waloszczyk; B Potocka-Banaś; A Machoy-Mokrzyńska; A Ossowski; A Ciechanowicz

The etiology of drug addiction, a central nervous system (CNS) disease, is not fully known. This complex problem is believed to be connected with concurrently affecting genetic, psychological and environmental factors. The development of addiction is connected with CNS reinforcement system and dopaminergic neurotransmission. Molecular processes are postulated to be of universal character and allow to presume a similar mechanism of dependence for both ethanol and other substances. Therefore, elements of dopaminergic transmission become excellent candidates for the examination of genetic influence on the development of addiction. A relationship between alcoholic disease and the presence of TaqIA1 and DRD2 alleles permits to initiate another investigation of gene-coding DRD2 dopamine receptor. The latest results indicate the importance of brain-derived neurotrophic factor (BDNF) in the regulation of dopaminergic route. The purpose of this research was to reveal the relationship between the Val66Met BDNF gene polymorphism and dependence of psychoactive agent. The examinations were performed with the Local Research Ethics Committee approval and patient’s consent. The study group consisted of 100 patients (88 men and 12 women) aged 18–52 years, qualified for research program according to the International Classification of Diseases, Tenth Revision (ICD-10) requirements, medical examination and detailed questionnaire.


Cell Stem Cell | 2018

Daily Onset of Light and Darkness Differentially Controls Hematopoietic Stem Cell Differentiation and Maintenance

Karin Golan; Anju Kumari; Orit Kollet; Eman Khatib-Massalha; Mohana Devi Subramaniam; Zulma S. Ferreira; Francesca Avemaria; Sylwia Rzeszotek; Andrés García-García; Stephanie Xie; Eugenia Flores-Figueroa; Shiri Gur-Cohen; Tomer Itkin; Aya Ludin-Tal; Hassan Massalha; Biana Bernshtein; Andrzej Ciechanowicz; Alexander Brandis; Tevie Mehlman; Suditi Bhattacharya; Mayla Bertagna; Hui Cheng; Ekaterina Petrovich-Kopitman; Tomasz Janus; Nathali Kaushansky; Tao Cheng; Irit Sagi; Mariusz Z. Ratajczak; Simón Méndez-Ferrer; John E. Dick

Hematopoietic stem and progenitor cells (HSPCs) tightly couple maintenance of the bone marrow (BM) reservoir, including undifferentiated long-term repopulating hematopoietic stem cells (LT-HSCs), with intensive daily production of mature leukocytes and blood replenishment. We found two daily peaks of BM HSPC activity that are initiated by onset of light and darkness providing this coupling. Both peaks follow transient elevation of BM norepinephrine and TNF secretion, which temporarily increase HSPC reactive oxygen species (ROS) levels. Light-induced norepinephrine and TNF secretion augments HSPC differentiation and increases vascular permeability to replenish the blood. In contrast, darkness-induced TNF increases melatonin secretion to drive renewal of HSPCs and LT-HSC potential through modulating surface CD150 and c-Kit expression, increasing COX-2/αSMA+ macrophages, diminishing vascular permeability, and reducing HSPC ROS levels. These findings reveal that light- and darkness-induced daily bursts of norepinephrine, TNF, and melatonin within the BM are essential for synchronized mature blood cell production and HSPC pool repopulation.


Handbook of Cannabis and Related Pathologies#R##N#Biology, Pharmacology, Diagnosis, and Treatment | 2017

Genetic and Molecular Aspects of Addiction with Tetrahydrocannabinol

Tomasz Janus; Anna Machoy-Mokrzyńska; Krzysztof Borowiak

Abstract Cannabis sativa derivatives (marijuana, hashish) are currently the most frequently self-administered “soft narcotics” worldwide. Δ9-Tetrahydrocannabinol (THC), as other psychoactive substances, leads to a chronic and recurrent central nervous system (CNS) disease, complex in terms of its etiology, molecular mechanisms, clinical course, and treatment. This phenomenon is thought to be influenced by several concurrently acting genetic, molecular, psychological, and social factors, but the molecular aspects of this process are not fully known yet. The discovery of specific THC receptors—cannabinoid receptors type 1 and 2 (CB1 and CB2)—was a decisive point in research of the biological activity of their compounds. The advance in the neuroscience and discovery of specific THC receptors from CB1 and CB2 class was crucial in research of the biological activity of this compounds but the molecular aspects of this process is not fully known yet. The biological activity of cannabinoids is closely connected with specific receptor–agonist interactions. The brain plasticity functional model offered a new perspective at the cellular and molecular mechanisms of dependence. The deregulation of the reward system of CNS, connected with stimulation of dopaminergic pathway of neurotransmission and CB receptors response, is believed to play a significant part in the addiction process. This mechanism of dependence development seems to be a universal process for most of addictive substances. A long-term exposure to THC action can influence the stimulation of genetically-related changes connected with stimulation of long-term response genes, resulting in irreversible DNA mutation. This process may explain the observed difficulties in successful treatment of addiction diseases. Apart from the natural THC residues, there exists a number of newly designed synthetic cannabinoids. Their structure relationship and biological activity are currently pivotal problems in investigations, because of the phenomena of their receptor related activity, regardless of the distinctly different chemical structures, in comparison with natural Δ9-THC


Diagnostic Pathology | 2011

Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material

Piotr Waloszczyk; Tomasz Janus; Jacek Alchimowicz; Tomasz Grodzki; Krzysztof Borowiak


Basic & Clinical Pharmacology & Toxicology | 2005

1H Nuclear Magnetic Resonance Spectroscopic Investigation of Urine for Diagnostic and Clinical Assessment of Methanol Intoxication

Tomasz Janus; Krzysztof Borowiak; Krzysztof Pabisiak; Anna Machoy-Mokrzyńska; Andrzej Swiniarski; Zbigniew Rozwadowski


Pomeranian journal of life sciences | 2018

Oznaczenie fentanylu i remifentanylu we krwi metodą chromatografii cieczowej sprzężonej z tandemową spektrometrią mas LC-MS/MS

Tomasz Janus; Barbara Potocka-Banaś; Ewa Jasionowicz; Krzysztof Borowiak; Izabela Polewczak


Pomeranian journal of life sciences | 2017

Analiza toksykologiczna peptydów w materiale biologicznym z wykorzystaniem spektrometrii mas na przykładzie oznaczania alfa-amanityny

Tomasz Janus; Ewa Jasionowicz; Barbara Potocka-Banaś; Krzysztof Borowiak


Archive | 2010

1 H Magnetic Resonance Spectroscopy of Urine for the Assessment of Renal Dysfunction in Healthy Pregnant Women* 1 H spektroskopia rezonansu magnetycznego moczu w ocenie zaburzeń czynności nerek u zdrowych kobiet będących w ciąży*

Aleksandra K. Majewska; Tomasz Janus; Tomasz Płonka; Krzysztof Borowiak

Collaboration


Dive into the Tomasz Janus's collaboration.

Top Co-Authors

Avatar

Krzysztof Borowiak

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sławomir Majdanik

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Grażyna Dutkiewicz

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Krzysztof Pabisiak

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Leszek Domański

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Tomasz Płonka

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexander Brandis

Weizmann Institute of Science

View shared research outputs
Researchain Logo
Decentralizing Knowledge